The alarmin–ILC2 axis as a candidate mechanism for persistent olfactory dysfunction in allergic rhinitis
Open Access
- 8 July 2026
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 17, 1867859
Abstract
Background: Allergic rhinitis (AR) is an underrecognized contributor to olfactory dysfunction (OD). Although smell loss in AR is commonly attributed to conductive obstruction, some patients exhibit persistent or disproportionate hyposmia despite improvement in nasal congestion, suggesting that additional sensorineural mechanisms may exist. Hypothesis: We hypothesize that, in a subset of patients with persistent, moderate-to-severe, type 2-high AR-associated OD without macroscopic olfactory cleft obstruction, allergen-induced epithelial stress in the olfactory cleft may activate an alarmin–ILC2/type 2 neuroimmune pathway. IL-33 and thymic stromal lymphopoietin (TSLP) released from epithelial or sustentacular cell populations, together with IL-25 and lipid mediator signals from tuft-like microvillar cells, may engage group 2 innate lymphoid cells (ILC2s) as early amplifiers within a broader type 2 inflammatory network. This response is proposed to contribute to three candidate injury modules: IL-13/STAT6-associated horizontal basal cell fate bias, IL-5/eosinophil-associated olfactory sensory neuron injury, and IL-4/IL-13-associated sustentacular cell dysfunction. Rationale and evidence gap: Current support is indirect and derives from murine olfactory inflammation models, ex vivo olfactory preparations, human non-olfactory nasal mucosal studies, and chronic rhinosinusitis with nasal polyps (CRSwNP) studies used as mechanistic analogies. None of the proposed mechanisms has been directly validated in human AR olfactory cleft tissue, which together represent the central evidence gap. Implications: The model generates falsifiable predictions regarding olfactory cleft alarmins, type 2 cytokines, ILC2-like immune niches, basal cell transcriptional state, and biomarker-linked responses in future proof-of-mechanism studies. It is presented as a hypothesis to guide future non-invasive biomarker studies, ethically feasible tissue analyses, organoid experiments, and biomarker-enriched proof-of-mechanism trials, not as a validated disease mechanism or current treatment recommendation.Keywords
This publication has 41 references indexed in Scilit:
- Which Is the Best Biologic for Nasal Polyps: An Updated Network Meta‐AnalysisClinical and Translational Allergy, 2025
- Olfactory Dysfunction in Allergic RhinitisClinical Reviews in Allergy & Immunology, 2024
- Chronic intranasal corticosteroid treatment induces degeneration of olfactory sensory neurons in normal and allergic rhinitis miceInternational Forum of Allergy & Rhinology, 2023
- Chronic interleukin‐13 expression in mouse olfactory mucosa results in regional aneuronal epitheliumInternational Forum of Allergy & Rhinology, 2022
- Interleukin-33 (IL-33): A critical review of its biology and the mechanisms involved in its release as a potent extracellular cytokineCytokine, 2022
- Construction of an irreversible allergic rhinitis-induced olfactory loss mouse modelBiochemical and Biophysical Research Communications, 2019
- International consensus statement on allergy and rhinology: allergic rhinitis—executive summaryInternational Forum of Allergy & Rhinology, 2018
- Olfactory and middle meatal cytokine levels correlate with olfactory function in chronic rhinosinusitisThe Laryngoscope, 2018
- Persistent allergic rhinitis has a moderate impact on the sense of smell, depending on both nasal congestion and inflammationThe Laryngoscope, 2009
- Neurogenesis and neuron regeneration in the olfactory system of mammals. I. Morphological aspects of differentiation and structural organization of the olfactory sensory neuronsJournal of Neurocytology, 1979